Merkliste 
 1 Ergebnisse 
 
1

S-1 and irinotecan plus bevacizumab as second-line chemothe..:

Miyamoto, Yuji ; Tsuji, Akihito ; Tanioka, Hiroaki...
International Journal of Clinical Oncology.  21 (2016)  4 - p. 705-712 , 2016